High-grade hyperinvasive sarcomatoid urothelial bladder carcinoma demonstrating complete response to bladder-preserving chemoradiation

被引:2
作者
Wallach, J. B. [1 ]
Wang, B. [1 ]
Sanfilippo, N. [1 ]
机构
[1] NYU, Med Ctr, New York, NY 10016 USA
关键词
Bladder carcinoma; sarcomatoid carcinoma; chemotherapy; radiation oncology; cystectomy; quality of life; bladder preservation; URINARY-BLADDER; THERAPY; CARCINOSARCOMA; PRESERVATION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The standard treatment for locally advanced urothelial bladder carcinoma is radical cystectomy or chemoradiation. Sarcomatoid urothelial carcinoma, a rare tumour, is treated with radical cystectomy because the response to radiation therapy alone is poor in other sarcomas. We report a case of high-grade hyperinvasive urothelial bladder carcinoma with sarcomatoid differentiation. The patient refused cystectomy, and so a chemoradiation regimen was devised for her treatment. She completed the regimen and has since demonstrated a complete response to chemoradiation therapy clinically and pathologically by biopsy. The patient has therefore been able to attain a complete response while preserving a functional bladder.
引用
收藏
页码:196 / 198
页数:3
相关论文
共 13 条
  • [1] Trends in smoking-related cancer incidence in Tarragona, Spain, 1980-96
    Borràs, J
    Borràs, JM
    Galceran, J
    Sánchez, V
    Moreno, V
    González, JR
    [J]. CANCER CAUSES & CONTROL, 2001, 12 (10) : 903 - 908
  • [2] Gender- and smoking-related bladder cancer risk
    Castelao, JE
    Yuan, JM
    Skipper, PL
    Tannenbaum, SR
    Gago-Dominguez, M
    Crowder, JS
    Ross, RK
    Yu, MC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (07): : 538 - 545
  • [3] Malignant non-urothelial neoplasms of the urinary bladder: A review
    Dahm, P
    Gschwend, RE
    [J]. EUROPEAN UROLOGY, 2003, 44 (06) : 672 - 681
  • [4] Froehner M, 2001, Urology, V58, P799, DOI 10.1016/S0090-4295(01)01343-7
  • [5] Case of carcinosarcoma of urinary bladder obtained a pathologically complete response by neoadjuvant chemoradiotherapy
    Hoshi, Senji
    Sasaki, Mituharu
    Muto, Akinori
    Suzuki, Kenichi
    Kobayashi, Takashi
    Tukigi, Masaaki
    Ono, Kunio
    Sugano, Osamu
    Saso, Shunichi
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (01) : 79 - 81
  • [6] Cancer statistics, 2007
    Jemal, Ahmedin
    Siegel, Rebecca
    Ward, Elizabeth
    Murray, Taylor
    Xu, Jiaquan
    Thun, Michael J.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) : 43 - 66
  • [7] Bladder preservation by combined modality therapy for invasive bladder cancer
    Kachnic, LA
    Kaufman, DS
    Heney, NM
    Althausen, AF
    Griffin, PP
    Zietman, AL
    Shipley, WU
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1022 - 1029
  • [8] Carcinosarcoma and sarcomatoid carcinoma of the bladder: Clinicopathological study of 41 cases
    Lopez-Beltran, A
    Pacelli, A
    Rothenberg, HJ
    Wollan, PC
    Zincke, H
    Blute, ML
    Bostwick, DG
    [J]. JOURNAL OF UROLOGY, 1998, 159 (05) : 1497 - 1503
  • [9] Non-transitional cell bladder carcinomas
    Manunta, A
    Vincendeau, S
    Kiriakou, G
    Lobel, B
    Guillé, FO
    [J]. BJU INTERNATIONAL, 2005, 95 (04) : 497 - 502
  • [10] Promotion of bladder cancer development and progression by androgen receptor signals
    Miyamoto, Hiroshi
    Yang, Zhiming
    Chen, Yei-Tsung
    Ishiguro, Hitoshi
    Uemura, Hiroji
    Kubota, Yoshinobu
    Nagashima, Yoji
    Chang, Yu-Jia
    Hu, Yueh-Chiang
    Tsai, Meng-Yin
    Yeh, Shuyuan
    Messing, Edward M.
    Chang, Chawnshang
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (07) : 558 - 568